If you were affected, free legal review is available — no obligation.
Learn how to participate in the class action and what compensation you may be entitled to.
Join the Class Action →Use our verification tool to confirm your letter matches this official AG filing.
Verify My Notice LetterThis case file references a public filing made with the state filing in TX. This website is not affiliated with, endorsed by, or operated by any state government agency.
Takeda Pharmaceuticals USA, Inc. was the subject of a data breach notification filed with the TX Attorney General. The AG filing was recorded on June 26, 2026. The breach or discovery date reported in the filing is February 9, 2026.
From the AG filing description
Takeda Pharmaceuticals USA, Inc. is a major subsidiary of a global research-intensive biopharmaceutical leader, dedicated to discovering, developing, and delivering transformative therapies across gastroenterology, rare diseases, oncology, neuroscience, and vaccines. Because of its pivotal role in the pharmaceutical and healthcare sectors, the company maintains vast repositories of deeply sensitive information. This includes comprehensive clinical trial participant records, detailed employee and contractor payroll files, proprietary research databases, and an intricate web of healthcare provider interactions. Consequently, the organization holds a high volume of personally identifiable information and protected health data necessary for regulatory compliance, clinical research, and operational continuity. In 2026, Takeda Pharmaceuticals USA, Inc. formally reported a significant cybersecurity incident to the Texas Attorney General. While the precise vectors of the attack continue to be scrutinized, security incidents affecting major pharmaceutical and life sciences corporations typically involve sophisticated network intrusions, unauthorized access to legacy databases, or third-party vendor compromises. In the pharmaceutical sector, these breaches often exploit vulnerabilities in digital supply chains or enterprise resource planning platforms, allowing malicious actors to dwell undetected within internal networks before exfiltrating large volumes of confidential corporate and personal records. The data exposed in corporate and healthcare-adjacent security incidents routinely encompasses a dangerous amalgamation of high-risk identifiers. When files containing names, dates of birth, Social Security numbers, banking details, and clinical trial health metrics are compromised, individuals face immediate and severe vulnerabilities. Exposure of Social Security numbers and financial details creates an acute risk of long-term identity theft, fraudulent credit card applications, and unauthorized tax filings. Meanwhile, the potential leakage of clinical trial data or employee health-related metadata introduces unique privacy violations, exposing vulnerable participants to targeted phishing schemes, medical identity theft, and the exploitation of confidential health profiles. As a major entity handling sensitive consumer and employee data within Texas, Takeda Pharmaceuticals USA, Inc. is bound by stringent legal and regulatory obligations. These include compliance with the Texas Identity Theft Enforcement and Protection Act, common law negligence standards, and industry-specific mandates governing data security. These legal frameworks require corporations to implement robust administrative, physical, and technical safeguards, such as end-to-end encryption, multi-factor authentication, and continuous network monitoring. The occurrence of a data breach of this magnitude serves as a strong indicator that the company may have failed to maintain reasonable security procedures, thereby breaching its legal duty to protect private information. Receiving an official data breach notification letter from Takeda Pharmaceuticals USA, Inc. is an admission that your confidential records were compromised due to corporate security failures. Legally, this notification establishes the necessary standing to participate in a class action lawsuit aimed at holding the company accountable for its oversight. You do not need to wait until you suffer actual financial loss or identity theft to take legal action; the increased risk of future harm alone is actionable. Our firm handles these complex data privacy cases on a strict contingency fee basis, meaning you pay absolutely nothing out of pocket and owe no legal fees unless we successfully recover compensation on your behalf.
Under the Texas Identity Theft Enforcement and Protection Act, you may have a legal claim against Takeda Pharmaceuticals USA, Inc. if any of the following apply:
Based on the data types reported in this filing:
Your SSN is the master key to your identity. Once exposed, criminals can open new lines of credit, take out loans, or file taxes in your name.
Combined with a name and other leaked data, date of birth helps criminals pass identity verification questions at banks and government agencies.
Common categories of compensation in data breach class actions
Courts recognize that the time spent monitoring accounts, placing credit freezes, and dealing with the aftermath of a breach has real economic value. This category of damages is recoverable even without direct financial loss.
Professional credit monitoring services cost $10–$40 per month. Identity theft restoration services, if needed, can cost hundreds of hours and thousands of dollars. Courts have awarded these costs as direct damages in SSN breach cases.
Several state data breach laws provide for statutory minimum damages — fixed amounts recoverable per affected individual regardless of actual loss. These provisions exist specifically to make legal action viable for victims who have not yet experienced direct harm.
Note: an attorney general breach filing does not by itself establish a settlement fund, a payment amount, or a claim deadline. If an official settlement notice is later issued, rely on that notice for payment details and deadlines.
No. Under Texas Identity Theft Enforcement and Protection Act and federal law, the unauthorized exposure of your personal data — regardless of whether it has been actively misused — can be sufficient grounds for a claim. The breach itself is the injury.
Nothing. The Law Office of David S. Harris handles data breach cases on contingency — you pay zero upfront and owe nothing unless compensation is recovered.
Immediately place a free credit freeze at all three bureaus (Equifax, Experian, TransUnion). A freeze blocks new accounts from being opened in your name. Then file a complaint with the FTC at IdentityTheft.gov and contact our office — SSN exposure is one of the most serious breach types.
State statutes of limitations for data breach claims typically run 2–4 years from the date of the breach or its discovery. Because this breach was recently disclosed, the window is open — but acting early preserves your options and strengthens the case.
Accepting free credit monitoring from Takeda Pharmaceuticals USA, Inc. does not waive your right to pursue legal action unless you signed a specific release waiving claims. In most cases, victims who accepted monitoring can still file.
Not necessarily. Many data breach victims are never notified directly. If your personal information was held by Takeda Pharmaceuticals USA, Inc. during the relevant period, you may still qualify even without receiving a letter. A free eligibility review can confirm your status.
Most data breach class actions resolve within 18 to 36 months, though timelines vary by court and complexity. Your participation requires minimal effort — typically completing a claim form. Our office handles all litigation; you are notified when a settlement is reached.
Applicable State Law
This breach was reported under the Texas Identity Theft Enforcement and Protection Act, which mandates notification and establishes your right to seek damages.
Takeda Pharmaceuticals USA, Inc. breach?
Free case review · No fee unless you win